These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31498123)

  • 21. Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    J Alzheimers Dis; 2017; 57(4):1251-1264. PubMed ID: 28304289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia.
    Ryan KA; Hammers D; DeLeon A; Bilen H; Frey K; Burke J; Albin R; Barbas N; Heidebrink J; Giordani B
    J Clin Neurosci; 2017 Oct; 44():128-132. PubMed ID: 28601570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis.
    Wenzel F; Young S; Wilke F; Apostolova I; Arlt S; Jahn H; Thiele F; Buchert R
    Neuroimage; 2010 Apr; 50(3):994-1003. PubMed ID: 20053378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study.
    Laforce R; Buteau JP; Paquet N; Verret L; Houde M; Bouchard RW
    Am J Alzheimers Dis Other Demen; 2010 Jun; 25(4):324-32. PubMed ID: 20539026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
    Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
    Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):141-150. PubMed ID: 28240379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.
    Rice L; Bisdas S
    Eur J Radiol; 2017 Sep; 94():16-24. PubMed ID: 28941755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Memory Profiles in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    Schubert S; Leyton CE; Hodges JR; Piguet O
    J Alzheimers Dis; 2016; 51(3):775-82. PubMed ID: 26890749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
    Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
    J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Value of Diffusion Tensor Imaging and Positron Emission Tomography in Early Stages of Frontotemporal Dementia.
    Krämer J; Lueg G; Schiffler P; Vrachimis A; Weckesser M; Wenning C; Pawlowski M; Johnen A; Teuber A; Wersching H; Meuth SG; Duning T
    J Alzheimers Dis; 2018; 63(1):239-253. PubMed ID: 29614640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
    Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
    Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India.
    Mukku SSR; Sivakumar PT; Nagaraj C; Mangalore S; Harbishettar V; Varghese M
    Asian J Psychiatr; 2019 Aug; 44():99-105. PubMed ID: 31336358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study).
    Matsuzono K; Hishikawa N; Yamashita T; Ohta Y; Sato K; Kono S; Deguchi K; Morihara R; Abe K
    J Alzheimers Dis; 2015; 48(1):279-86. PubMed ID: 26401947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical staging of semantic dementia in an FDG-PET study using FTLD-CDR.
    Kim EJ; Kim BC; Kim SJ; Jung DS; Sin JS; Yoon YJ; Chin J; Lee KH; Na DL
    Dement Geriatr Cogn Disord; 2012; 34(5-6):300-6. PubMed ID: 23208196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.